Core Insights - QIAGEN N.V. has filed its annual report on Form 20-F for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission [1] - The report includes audited consolidated financial statements and is accessible on QIAGEN's website [1] Company Overview - QIAGEN is a Netherlands-based holding company and a global leader in Sample to Insight solutions, enabling the extraction and analysis of molecular information from biological samples [3] - The company serves over 500,000 customers worldwide in Life Sciences and molecular diagnostics, employing approximately 5,700 people across more than 35 locations as of December 31, 2025 [3][10] - QIAGEN reported revenues of US$ 1.97 billion and a net income of US$ 341.3 million for the year 2023 [6][11]